Literature DB >> 21081969

Discriminative accuracy of genomic profiling comparing multiplicative and additive risk models.

Ramal Moonesinghe1, Muin J Khoury, Tiebin Liu, A Cecile J W Janssens.   

Abstract

Genetic prediction of common diseases is based on testing multiple genetic variants with weak effect sizes. Standard logistic regression and Cox Proportional Hazard models that assess the combined effect of multiple variants on disease risk assume multiplicative joint effects of the variants, but this assumption may not be correct. The risk model chosen may affect the predictive accuracy of genomic profiling. We investigated the discriminative accuracy of genomic profiling by comparing additive and multiplicative risk models. We examined genomic profiles of 40 variants with genotype frequencies varying from 0.1 to 0.4 and relative risks varying from 1.1 to 1.5 in separate scenarios assuming a disease risk of 10%. The discriminative accuracy was evaluated by the area under the receiver operating characteristic curve. Predicted risks were more extreme at the lower and higher risks for the multiplicative risk model compared with the additive model. The discriminative accuracy was consistently higher for multiplicative risk models than for additive risk models. The differences in discriminative accuracy were negligible when the effect sizes were small (<1.2), but were substantial when risk genotypes were common or when they had stronger effects. Unraveling the exact mode of biological interaction is important when effect sizes of genetic variants are moderate at the least, to prevent the incorrect estimation of risks.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21081969      PMCID: PMC3025793          DOI: 10.1038/ejhg.2010.165

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  17 in total

1.  Polygenic susceptibility to breast cancer and implications for prevention.

Authors:  Paul D P Pharoah; Antonis Antoniou; Martin Bobrow; Ron L Zimmern; Douglas F Easton; Bruce A J Ponder
Journal:  Nat Genet       Date:  2002-03-04       Impact factor: 38.330

Review 2.  Receiver operating characteristic (ROC) methodology: the state of the art.

Authors:  J A Hanley
Journal:  Crit Rev Diagn Imaging       Date:  1989

3.  Additive and multiplicative models for the joint effect of two risk factors.

Authors:  A Berrington de González; D R Cox
Journal:  Biostatistics       Date:  2005-01       Impact factor: 5.899

4.  Graphical presentation of distributions of risk in screening.

Authors:  J K Morris; N J Wald
Journal:  J Med Screen       Date:  2005       Impact factor: 2.136

5.  Cumulative association of five genetic variants with prostate cancer.

Authors:  S Lilly Zheng; Jielin Sun; Fredrik Wiklund; Shelly Smith; Pär Stattin; Ge Li; Hans-Olov Adami; Fang-Chi Hsu; Yi Zhu; Katarina Bälter; A Karim Kader; Aubrey R Turner; Wennuan Liu; Eugene R Bleecker; Deborah A Meyers; David Duggan; John D Carpten; Bao-Li Chang; William B Isaacs; Jianfeng Xu; Henrik Grönberg
Journal:  N Engl J Med       Date:  2008-01-16       Impact factor: 91.245

6.  High constant incidence in twins and other relatives of women with breast cancer.

Authors:  J Peto; T M Mack
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

7.  Epidemiologic evaluation of screening for risk factors: application to genetic screening.

Authors:  M J Khoury; C A Newill; G A Chase
Journal:  Am J Public Health       Date:  1985-10       Impact factor: 9.308

8.  Comparison of additive and multiplicative models for reproductive risk factors and post-menopausal breast cancer.

Authors:  E Lund
Journal:  Stat Med       Date:  1995-02-15       Impact factor: 2.373

9.  Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

Authors:  Steven J Skates; Nora Horick; Yinhua Yu; Feng-Ji Xu; Andrew Berchuck; Laura J Havrilesky; Henk W A de Bruijn; Ate G J van der Zee; Robert P Woolas; Ian J Jacobs; Zhen Zhang; Robert C Bast
Journal:  J Clin Oncol       Date:  2004-09-20       Impact factor: 44.544

10.  Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses.

Authors:  R P Woolas; M R Conaway; F Xu; I J Jacobs; Y Yu; L Daly; A P Davies; K O'Briant; A Berchuck; J T Soper
Journal:  Gynecol Oncol       Date:  1995-10       Impact factor: 5.482

View more
  8 in total

1.  The benefits of using genetic information to design prevention trials.

Authors:  Youna Hu; Li Li; Margaret G Ehm; Nan Bing; Kijoung Song; Matthew R Nelson; Philippa J Talmud; Aroon D Hingorani; Meena Kumari; Mika Kivimäki; Chun-Fang Xu; Dawn M Waterworth; John C Whittaker; Gonçalo R Abecasis; Cathie Spino; Hyun Min Kang
Journal:  Am J Hum Genet       Date:  2013-03-28       Impact factor: 11.025

2.  Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.

Authors:  Amit D Joshi; Sara Lindström; Anika Hüsing; Myrto Barrdahl; Tyler J VanderWeele; Daniele Campa; Federico Canzian; Mia M Gaudet; Jonine D Figueroa; Laura Baglietto; Christine D Berg; Julie E Buring; Stephen J Chanock; María-Dolores Chirlaque; W Ryan Diver; Laure Dossus; Graham G Giles; Christopher A Haiman; Susan E Hankinson; Brian E Henderson; Robert N Hoover; David J Hunter; Claudine Isaacs; Rudolf Kaaks; Laurence N Kolonel; Vittorio Krogh; Loic Le Marchand; I-Min Lee; Eiliv Lund; Catherine A McCarty; Kim Overvad; Petra H Peeters; Elio Riboli; Fredrick Schumacher; Gianluca Severi; Daniel O Stram; Malin Sund; Michael J Thun; Ruth C Travis; Dimitrios Trichopoulos; Walter C Willett; Shumin Zhang; Regina G Ziegler; Peter Kraft
Journal:  Am J Epidemiol       Date:  2014-09-25       Impact factor: 4.897

3.  Testing calibration of risk models at extremes of disease risk.

Authors:  Minsun Song; Peter Kraft; Amit D Joshi; Myrto Barrdahl; Nilanjan Chatterjee
Journal:  Biostatistics       Date:  2014-07-14       Impact factor: 5.899

4.  Direct to consumer testing in reproductive contexts--should health professionals be concerned?

Authors:  Heather Skirton
Journal:  Life Sci Soc Policy       Date:  2015-04-29

5.  Estimating the predictive ability of genetic risk models in simulated data based on published results from genome-wide association studies.

Authors:  Suman Kundu; Raluca Mihaescu; Catherina M C Meijer; Rachel Bakker; A Cecile J W Janssens
Journal:  Front Genet       Date:  2014-06-13       Impact factor: 4.599

6.  Risk prediction for complex diseases: application to Parkinson disease.

Authors:  Taryn O Hall; Jia Y Wan; Ignacio F Mata; Kathleen F Kerr; Katherine W Snapinn; Ali Samii; John W Roberts; Pinky Agarwal; Cyrus P Zabetian; Karen L Edwards
Journal:  Genet Med       Date:  2012-12-06       Impact factor: 8.822

7.  Variations in predicted risks in personal genome testing for common complex diseases.

Authors:  Rachel R J Kalf; Raluca Mihaescu; Suman Kundu; Peter de Knijff; Robert C Green; A Cecile J W Janssens
Journal:  Genet Med       Date:  2013-06-27       Impact factor: 8.822

Review 8.  Validity of polygenic risk scores: are we measuring what we think we are?

Authors:  A Cecile J W Janssens
Journal:  Hum Mol Genet       Date:  2019-11-21       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.